Menu
About Us
About Imunexus Therapeutics
Board of Directors
Executive Team
Our Philosophy
Technology
Technology Approach
Multispecific Antibodies
Lead Product Candidates
Current Pipeline
News & Events
Company News
Conferences
Investors
Why Invest
Investor News
Corporate Governance
Email Alerts
Contact
Partnerships
Contact Us
News
Recent Posts
Immunexus’ Engage New Science Team
Imunexus R&D activities relocated to LIMS building
Recommencement of Operations
Successful Capital Raise
Archives
August 2021
July 2021
April 2021
March 2021
August 1st, 2021
Immunexus’ Engage New Science Team
Read More
1